Although the antibody-based recognition of cell-surface markers has been widely used for the identification of immune cells, overlap in the expression of markers by different cell types and the inconsistent use of antibody panels have resulted in a lack of clearly defined signatures for myeloid cell subsets. We developed a 10-fluorochrome flow cytometry panel for the identification and quantitation of myeloid cells in the lungs, including pulmonary monocytes, myeloid dendritic cells, alveolar and interstitial macrophages, and neutrophils. After the initial sorting of viable CD451 leukocytes, we detected three leukocyte subpopulations based on CD68 expression: CD68
/CD11b1 /Gr1 hi ). The validity of cellular signatures was confirmed by a morphological analysis of FACS-sorted cells, functional studies, and the depletion of specific macrophage subpopulations using liposomal clodronate. We believe our approach provides an accurate and reproducible method for the isolation, quantification, and characterization of myeloid cell subsets in the lungs, which may be useful for studying the roles of myeloid cells during various pathological processes.Keywords: interstitial macrophages; alveolar macrophages; monocytes; myeloid dendritic cells; neutrophilsThe heterogeneous population of myeloid cells in the lungs is important for maintaining homeostasis and regulating inflammation, injury, and remodeling. These cells are thought to originate from bone marrow-derived precursors, and they differentiate into mature cells with a variety of functional properties, depending on environmental cues. Multiple studies have demonstrated functional and phenotypic differences between myeloid cell subsets, including monocytes, myeloid dendritic cells, macrophages, and neutrophils. However, the specific identification and quantification of subsets of these cells in tissues are complex, and a comprehensive scheme for isolating these cells from the lungs is not readily available. To date, studies of lung myeloid cells have been limited by the inconsistent use of cellular markers and a lack of clearly defined signatures for these cells, resulting in difficulties comparing studies from different laboratories and generalizing findings across different model systems. Therefore, we undertook a study to identify and quantify myeloid cell populations comprehensively in the lungs, using flow cytometry.Based on the recent explosion of information regarding the mechanisms that underpin innate immune responses, a clear need is apparent for better strategies to identify and study myeloid cell subpopulations in the lungs. The traditional method for the identification and quantification of lung myeloid cells involves the manual counting of cells obtained from the airways by bronchoalveolar lavage (BAL). This methodology normally yields a predominance of alveolar macrophages, because these are the primary immune cells in the airspaces. Interstitial macrophages, however, comprise a substantial portion of the lung myeloid cell population (1), and may have dif...